AKBM Fundamental Analysis - AKER BIOMARINE ASA

Fundamental Rating

Overall AKBM gets a fundamental rating of 4 out of 10. We evaluated AKBM against 59 industry peers in the Food Products industry. While AKBM is still in line with the averages on profitability rating, there are concerns on its financial health. AKBM has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AKBM had positive earnings in the past year.

In the past year AKBM had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.

Of the past 5 years AKBM 4 years had a positive operating cash flow.

1.2 Ratios

AKBM has a Return On Assets of 44.73%. This is amongst the best in the industry. AKBM outperforms 100.00% of its industry peers.

AKBM's Return On Equity of 115.79% is amongst the best of the industry. AKBM outperforms 100.00% of its industry peers.

The Return On Invested Capital of AKBM (1.30%) is worse than 77.97% of its industry peers.

		Industry Rank	Sector Rank
ROA	44.73%
ROE	115.79%
ROIC	1.3%

ROA(3y)16.04%

ROA(5y)9.26%

ROE(3y)36.62%

ROE(5y)21.25%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 67.04%, AKBM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

AKBM has a Operating Margin of 2.05%. This is in the lower half of the industry: AKBM underperforms 69.49% of its industry peers.

The Gross Margin of AKBM (43.26%) is comparable to the rest of the industry.

AKBM's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	2.05%
PM (TTM)	67.04%
GM	43.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.45%

GM growth 5Y0.36%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKBM is destroying value.

Compared to 1 year ago, AKBM has about the same amount of shares outstanding.

The number of shares outstanding for AKBM remains at a similar level compared to 5 years ago.

The debt/assets ratio for AKBM has been reduced compared to a year ago.

2.2 Solvency

AKBM has an Altman-Z score of 1.59. This is a bad value and indicates that AKBM is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.59, AKBM is doing worse than 69.49% of the companies in the same industry.

AKBM has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.06, AKBM is not doing good in the industry: 72.88% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Altman-Z	1.59

ROIC/WACC0.15

WACC8.47%

2.3 Liquidity

AKBM has a Current Ratio of 2.62. This indicates that AKBM is financially healthy and has no problem in meeting its short term obligations.

AKBM has a Current ratio of 2.62. This is amongst the best in the industry. AKBM outperforms 88.14% of its industry peers.

AKBM has a Quick Ratio of 1.25. This is a normal value and indicates that AKBM is financially healthy and should not expect problems in meeting its short term obligations.

AKBM's Quick ratio of 1.25 is fine compared to the rest of the industry. AKBM outperforms 77.97% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.62
Quick Ratio	1.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AKBM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15747.24%, which is quite impressive.

The Revenue for AKBM has decreased by -15.34% in the past year. This is quite bad

The Revenue has been decreasing by -4.17% on average over the past years.

EPS 1Y (TTM)15747.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)-15.34%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-41.17%

3.2 Future

The Earnings Per Share is expected to grow by 97.75% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 20.59% on average over the next years. This is a very strong growth

EPS Next Y100%

EPS Next 2Y119.09%

EPS Next 3Y97.75%

EPS Next 5YN/A

Revenue Next Year-14.23%

Revenue Next 2Y-1.01%

Revenue Next 3Y2.72%

Revenue Next 5Y20.59%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.61 indicates a rather cheap valuation of AKBM.

Based on the Price/Earnings ratio, AKBM is valued cheaply inside the industry as 96.61% of the companies are valued more expensively.

The average S&P500 Price/Earnings ratio is at 27.07. AKBM is valued rather cheaply when compared to this.

The Price/Forward Earnings ratio is 37.40, which means the current valuation is very expensive for AKBM.

Based on the Price/Forward Earnings ratio, AKBM is valued a bit more expensive than the industry average as 71.19% of the companies are valued more cheaply.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.59, AKBM is valued quite expensively.

		Industry Rank	Sector Rank
PE	4.61
Fwd PE	37.4

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKBM is valued a bit more expensive than the industry average as 79.66% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	21.26

4.3 Compensation for Growth

AKBM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as AKBM's earnings are expected to grow with 97.75% in the coming years.

PEG (NY)0.05

PEG (5Y)N/A

EPS Next 2Y119.09%

EPS Next 3Y97.75%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AKBM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (9/10/2025, 11:14:37 AM)

91.3

+0.2 (+0.22%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)07-11 2025-07-11/bmo

Earnings (Next)10-31 2025-10-31

Inst Owners8.28%

Inst Owner ChangeN/A

Ins Owners3.18%

Ins Owner ChangeN/A

Market Cap8.01B

Analysts77.78

Price Target86.7 (-5.04%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend42.76

Dividend Growth(5Y)N/A

DP215.6%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)21.43%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)11.11%

EPS NY rev (3m)11.11%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.44%

Valuation

		Industry Rank	Sector Rank
PE	4.61
Fwd PE	37.4
P/S	3.11
P/FCF	N/A
P/OCF	195.85
P/B	5.37
P/tB	29.31
EV/EBITDA	21.26

EPS(TTM)19.82

EY21.71%

EPS(NY)2.44

Fwd EY2.67%

FCF(TTM)-1.73

FCFYN/A

OCF(TTM)0.47

OCFY0.51%

SpS29.36

BVpS17

TBVpS3.12

PEG (NY)0.05

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	44.73%
ROE	115.79%
ROCE	1.69%
ROIC	1.3%
ROICexc	1.39%
ROICexgc	2.38%
OM	2.05%
PM (TTM)	67.04%
GM	43.26%
FCFM	N/A

ROA(3y)16.04%

ROA(5y)9.26%

ROE(3y)36.62%

ROE(5y)21.25%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.45%

GM growth 5Y0.36%

F-Score5

Asset Turnover0.67

Health

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Debt/EBITDA	3.5
Cap/Depr	48.25%
Cap/Sales	7.47%
Interest Coverage	0.39
Cash Conversion	9.05%
Profit Quality	N/A
Current Ratio	2.62
Quick Ratio	1.25
Altman-Z	1.59

F-Score5

WACC8.47%

ROIC/WACC0.15

Cap/Depr(3y)77.43%

Cap/Depr(5y)88.04%

Cap/Sales(3y)14.31%

Cap/Sales(5y)16.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15747.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y100%

EPS Next 2Y119.09%

EPS Next 3Y97.75%

EPS Next 5YN/A

Revenue 1Y (TTM)-15.34%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-41.17%

Revenue Next Year-14.23%

Revenue Next 2Y-1.01%

Revenue Next 3Y2.72%

Revenue Next 5Y20.59%

EBIT growth 1Y60.61%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year177.08%

EBIT Next 3Y69.2%

EBIT Next 5YN/A

FCF growth 1Y62.56%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-14.58%

OCF growth 3Y155.79%

OCF growth 5Y-0.17%

AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens